{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:38:15Z","timestamp":1788388695728,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences (NCATS)","doi-asserted-by":"crossref","award":["#UL1TR000067"],"award-info":[{"award-number":["#UL1TR000067"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ymgme.2015.05.013","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T15:45:13Z","timestamp":1433000713000},"page":"88-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency"],"prefix":"10.1016","volume":"116","author":[{"given":"Melissa P.","family":"Wasserstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handrean","family":"Soran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Lippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Culm-Merdek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Shamiyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haig","family":"Inguilizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Puga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2015.05.013_bb0005","series-title":"Orphanet Report Series \u2014 Prevalence of Rare Diseases: Bibliographic Data Number 1 May 2014","article-title":"Prevalence of rare diseases: bibliographic data listed in order of decreasing prevalence or number of published cases","year":"2014"},{"issue":"2","key":"10.1016\/j.ymgme.2015.05.013_bb0010","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2007-3016","article-title":"A prospective, cross-sectional survey study of the natural history of Niemann\u2013Pick disease type B","volume":"122","author":"McGovern","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2015.05.013_bb0015","series-title":"OMMBID\u2014The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Niemann\u2013Pick disease types A and B: acid sphingomyelinase deficiencies","author":"Schuchman","year":"2013"},{"issue":"2","key":"10.1016\/j.ymgme.2015.05.013_bb0020","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1212\/01.wnl.0000194208.08904.0c","article-title":"Natural history of type A Niemann\u2013Pick disease: possible endpoints for therapeutic trials","volume":"66","author":"McGovern","year":"2006","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ymgme.2015.05.013_bb0025","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann\u2013Pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2015.05.013_bb0030","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann\u2013Pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ymgme.2015.05.013_bb0035","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10545-012-9503-0","article-title":"Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B","volume":"36","author":"Wasserstein","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"13","key":"10.1016\/j.ymgme.2015.05.013_bb0040","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into Niemann\u2013Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.ymgme.2015.05.013_bb0045","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ymgme.2014.07.005","article-title":"Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: The utility of animal models of disease in the toxicological evaluation of potential therapeutics","volume":"114","author":"Murray","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.05.013_bb0050","article-title":"Novel first-dose adverse drug reactions during a phase 1 trial of recombinant human acid sphingomyelinase (rhASM) in adults with Niemann\u2013Pick disease type B (acid sphingomyelinase deficiency)","author":"McGovern","year":"2015","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.ymgme.2015.05.013_bb0055","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","article-title":"Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann\u2013Pick disease type B)","volume":"36","author":"Thurberg","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.ymgme.2015.05.013_bb0060","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1148\/radiol.2381041696","article-title":"Type B Niemann\u2013Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing","volume":"238","author":"Mendelson","year":"2006","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ymgme.2015.05.013_bb0065","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.ymgme.2015.05.013_bb0070","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","article-title":"The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory","volume":"85","author":"Mendoza","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ymgme.2015.05.013_bb0075","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann. Acad. Med. Singap."},{"issue":"439","key":"10.1016\/j.ymgme.2015.05.013_bb0080","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1651-2227.2002.tb03109.x","article-title":"Pain assessment: the advantages of using pain scales in lysosomal storage diseases","volume":"91","author":"Cleeland","year":"2002","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2015.05.013_bb0085","series-title":"Surgical Pathology of the GI Tract, Liver, Billiary Tract and Pancreas","author":"Odze","year":"2004"},{"issue":"1","key":"10.1016\/j.ymgme.2015.05.013_bb0090","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.ymgme.2015.05.013_bb0095","first-page":"270","article-title":"Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history","volume":"127","author":"Miller","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2015.05.013_bb0100","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3343\/alm.2012.32.5.319","article-title":"Analysis of acid sphingomyelinase activity in dried blood spots using tandem mass spectrometry","volume":"32","author":"Legnini","year":"2012","journal-title":"Ann. Lab. Med."},{"issue":"10","key":"10.1016\/j.ymgme.2015.05.013_bb0105","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1373\/clinchem.2008.104711","article-title":"Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry","volume":"54","author":"Zhang","year":"2008","journal-title":"Clin. Chem."},{"issue":"Supple 5","key":"10.1016\/j.ymgme.2015.05.013_bb0110","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ymgme.2015.05.013_bb0115","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000328812","article-title":"Iron balance in regular blood donors","volume":"38","author":"Mozaheb","year":"2011","journal-title":"Transfus. Med. Hemother."},{"issue":"5","key":"10.1016\/j.ymgme.2015.05.013_bb0120","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"4\u20135","key":"10.1016\/j.ymgme.2015.05.013_bb0125","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1529-1049(02)00049-1","article-title":"Immunologic considerations for enzyme replacement therapy in the treatment of lysosomal storage disorders","volume":"2","author":"Richards","year":"2002","journal-title":"Clin. Appl. Immunol. Rev."},{"issue":"2","key":"10.1016\/j.ymgme.2015.05.013_bb0130","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ymgme.2006.09.003","article-title":"The long-term international safety experience of imiglucerase therapy for Gaucher disease","volume":"90","author":"Starzyk","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.05.013_bb0135","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ymgme.2008.08.004","article-title":"Characterization of common SMPD1 mutations causing types A and B Niemann\u2013Pick disease and generation of mutation-specific mouse models","volume":"95","author":"Jones","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2015.05.013_bb0140","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1210\/jc.2010-0597","article-title":"Characterization of and risk factors for the acute-phase response after zoledronic acid","volume":"95","author":"Reid","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2015.05.013_bb0145","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0955-0674(96)80061-5","article-title":"Signal transduction through lipid second messengers","volume":"8","author":"Spiegel","year":"1996","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6","key":"10.1016\/j.ymgme.2015.05.013_bb0150","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00109-004-0539-y","article-title":"Ceramide, membrane rafts and infections","volume":"82","author":"Gulbins","year":"2004","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"5","key":"10.1016\/j.ymgme.2015.05.013_bb0155","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1074\/jbc.273.5.2738","article-title":"Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development","volume":"273","author":"Schissel","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2015.05.013_bb0160","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ymgme.2015.05.013_bb0165","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s10545-006-0318-8","article-title":"CCL18: a urinary marker of Gaucher cell burden in Gaucher patients","volume":"29","author":"Boot","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2015.05.013_bb0170","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10545-005-0585-9","article-title":"Evaluation of three biochemical markers in the monitoring of Gaucher disease","volume":"28","author":"Vellodi","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2015.05.013_bb0175","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpeds.2004.02.048","article-title":"Lipid abnormalities in children with types A and B Niemann Pick disease","volume":"145","author":"McGovern","year":"2004","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2015.05.013_bb0180","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10545-012-9529-3","article-title":"Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study","volume":"36","author":"Zimmermann","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.05.013_bb0185","series-title":"Technical Briefs","article-title":"Enzyme-Replacement Therapies for Lysosomal Storage Diseases [Internet].; 2013 Jan. (Technical Briefs, No. 12.)","author":"Ratko","year":"2013"},{"issue":"6","key":"10.1016\/j.ymgme.2015.05.013_bb0190","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40265-014-0210-z","article-title":"Elosulfase alfa: first global approval","volume":"74","author":"Sanford","year":"2014","journal-title":"Drugs"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215300196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215300196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T06:58:51Z","timestamp":1537599531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719215300196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1096719215300196"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.05.013","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}